Measurements of 18F-Fluciclovine Avidity in Primary Breast Malignancies, Axillary Nodes, and Extraaxillary Nodes
| By histology | ||||||||||
| All patients (n = 27) | IDC (n = 19) | ILC (n = 8) | ||||||||
| Lesion site | Measurements of avidity | n | Median | Minimum to maximum | n | Median | Minimum to maximum | n | Median | Minimum to maximum |
| Breast malignancy | SUVmax | 27 | 5.9 | 1.7–17.0 | 19 | 6.8 | 2.6–17.0 | 8 | 4.6 | 1.7–10.9 |
| SUVmean | 3.3 | 1.4–7.1 | 3.9 | 1.5–7.1 | 2.6 | 1.4–5.8 | ||||
| MTV | 16.1 | 3.2–102.0 | 15.3 | 3.2–74.6 | 32.6 | 3.6–102.0 | ||||
| TLA | 56.8 | 5.0–370.6 | 54.5 | 14.8–283.7 | 89.6 | 5.0–370.6 | ||||
| Axillary nodes | SUVmax | 20 | 5.6 | 1.2–14.6 | 16 | 5.4 | 1.2–12.6 | 4 | 7.0 | 1.3–14.6 |
| SUVmean | 3.3 | 1.0–7.9 | 3.2 | 1.0–7.9 | 4.2 | 1.2–6.2 | ||||
| MTV | 4.4 | 1.0–22.1 | 4.9 | 1.0–13.4 | 3.2 | 1.1–22.1 | ||||
| TLA | 12.6 | 1.0–137.0 | 13.8 | 1.0–52.3 | 12.6 | 1.3–137.0 | ||||
| Extraaxillary nodes | SUVmax | 3 | 2.6 | 2.2–4.2 | 3 | 2.6 | 2.2–4.2 | 0 | ||
| SUVmean | 1.8 | 1.8–3.3 | 1.8 | 1.8–3.3 | ||||||
| MTV | 1.4 | 1.1–1.8 | 1.4 | 1.1–1.8 | ||||||
| TLA | 3.2 | 2.0–4.6 | 3.2 | 2.0–4.6 | ||||||